Researchers analyze prostate cancer incidence over 20 years in men aged 45-70 years without prostate cancer and identify ...

Phase 3 trial data show datopotamab deruxtecan reduces the risk of disease progression or death in patients with metastatic TNBC.

The FDA accepted a supplemental biologics license application and granted priority review for Datroway for adults ...

The Trump administration has made the future of federal funding for cancer research uncertain. At one groundbreaking breast ...

The FDA granted Breakthrough Therapy status to zovegalisib plus Faslodex for patients with PIK3CA-mutated HR+/HER2- advanced breast cancer. The U.S. Food and Drug Administration (FDA) has granted ...

A report published Friday by Vermont Senator Bernie Sanders, the ranking member of the Senate Health, Education, Labor and ...

Over the last 12 months, PanCAN stood in strong opposition to the administration’s threats to severely reduce federal funding ...

Across the United States, the future of federal funding for cancer research is uncertain. President Donald Trump has proposed ...

This year, the Grammy Awards did more than deliver star‑studded performances: It delivered hope. At Crypto.com Arena in Los ...

Yosemite, which funds startups and researchers working on the disease, is targeting a total of $350 million for its second fund from high-powered investors like pharma giant Amgen and hospital ...

After reports flagged Iowa’s high cancer rates, communities across the state are taking action, using local data to address ...